Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppression for lung transplantation.

James S Allan1

  • 1Division of Thoracic Surgery, the Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. jallan@partners.org

Seminars in Thoracic and Cardiovascular Surgery
|January 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac allograft tolerance can be achieved in nonhuman primates by donor bone marrow and kidney cotransplantation.

Science translational medicine·2025
Same author

A novel technique for heart-thymus en bloc transplantation in nonhuman primates.

Scientific reports·2024
Same author

The role of induction therapy in lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2024
Same author

Novel approaches for long-term lung transplant survival.

Frontiers in immunology·2022
Same author

Expert Opinion Special Feature: Patient Selection for Initial Clinical Trials of Pig Organ Transplantation.

Transplantation·2022
Same author

Management and outcomes of esophageal perforation.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2021
Same journal

A Systematic Review on the Impact of Postoperative Rehabilitation Programs in Thoracic Surgery Patients.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Endoscopic vs. Operative Management of Acute Esophageal Perforation: A 21-Year Experience at a High-Volume Referral Center.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Valved Sano Conduit During the Norwood Procedure: A Contemporary Review of Early Outcomes, Reintervention Burden, and Pulmonary Artery Growth.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Propensity Score-Matched Analysis Comparing Modified Konno Procedure and Transaortic Septal Myectomy in Children With Left Ventricular Outflow Tract Obstruction.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Post-Operative Hemothorax: Uniportal Video-Assisted Thoracic Surgery vs Thoracotomy-Analysis of Outcomes and Costs.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Palliative Care Throughout the Entire Perioperative Pathway in Cardiovascular Surgery.

Seminars in thoracic and cardiovascular surgery·2026
See all related articles

Lung transplantation survival is limited by allograft rejection and infection. Current immunosuppression strategies face a paradox, balancing rejection prevention with infection/malignancy risks.

Area of Science:

  • Medicine
  • Surgery
  • Immunology

Background:

  • Lung transplantation is a viable treatment for end-stage lung disease.
  • Current 1-year survival rates approach 75%.
  • Long-term success is hindered by acute and chronic lung allograft rejection.

Purpose of the Study:

  • To review current immunosuppressive therapy for lung transplantation.
  • To suggest alternative management strategies for lung transplant recipients.

Main Methods:

  • Review of current immunosuppressive agents.
  • Analysis of therapeutic paradox in immunosuppression.
  • Examination of mortality causes in lung transplant recipients.

Main Results:

Related Experiment Videos

  • Immunosuppression presents a paradox: insufficient levels cause rejection, while excessive levels increase infection and malignancy risks.
  • Graft rejection, infection, and malignancy are primary causes of mortality.
  • Graft loss is often fatal due to limited support and donor graft scarcity.

    • Conclusions:

    • Current immunosuppressive protocols require careful balancing to avoid adverse outcomes.
    • Alternative paradigms are needed to improve long-term lung transplant outcomes.
    • Addressing rejection, infection, and malignancy is crucial for recipient survival.